Reintroducing Flap Reconstruction: One Institution's Safe Return to Flap Surgery during the COVID-19 Pandemic

Abstract

Background Prevention of nosocomial coronavirus disease 2019 (COVID-19) infection for patients undergoing flap-based reconstructive surgery is crucial to providing care and maintaining operative volume and income to support plastic surgery programs. We conducted this study to (1) determine the postoperative incidence of COVID-19 among patients undergoing flap reconstruction from December 1, 2019 to November 1, 2020 and (2) compare 30-day outcomes between patients who underwent surgery before and during the early pandemic.

Methods We conducted an 11-month retrospective cohort study of all patients who underwent flap reconstruction across our institution. We abstracted patient demographics, intraoperative management, COVID-19 testing history, and 30-day postoperative complications from electronic health records. Nosocomial COVID-19 infection was defined as reverse transcription polymerase chain reaction (RT-PCR) viral ribonucleic acid detection within 30 days of patients' postoperative course or during initial surgical admission. We used chi-squared tests to compare postoperative outcomes between patients who underwent surgery before (prior to March 12, 2021, when our institution admitted its first COVID-19 patient) versus during (on/after March 12, 2021) the pandemic.

Results Among the 220 patients (mean [standard deviation] age = 53.8 [18.1] years; female = 54.8%) who underwent flap reconstruction, none had nosocomial COVID-19 infection. Five (2%) patients eventually tested COVID-19 positive (median time from surgery to diagnosis: 9 months, range: 1.5–11 months) with one developing partial flap loss while infected. Between patients who underwent free flap surgery before and during the pandemic, there were no significant differences in 30-day takebacks (15.6% vs. 16.6%, respectively; p > 0.999), readmissions (9.4% vs. 12.6%, respectively; p = 0.53), and surgical complications (e.g., total flap loss 1.6% vs. 2.1%, p = 0.81).

Conclusion Robust precautions can ensure the safety of patients undergoing flap surgeries across an academic medical institution, even during periods of high COVID-19 admission rates. Further studies are needed to generate evidence-based guidelines that optimize infection control and flap survival for patients undergoing reconstruction.

Keywords

COVID-19 - clinical practice guidelines - pandemic - reconstructive surgery - flap reconstruction

Author Disclosure

The authors have no relevant financial disclosures to declare and there was no funding obtained for the production of this article.

^‡ Equally contributed as co-last authors.

Publication History

Received: 01 October 2021

Accepted: 22 March 2022

Article published online:
07 July 2022

• References

• 1 Ahmad FB, Anderson RN. The leading causes of death in the US for 2020 Farida. JAMA 2020; 173 (12) 1022-1023
• 2 Aleem A, Akbar Samad AB, Slenker AK. Emerging Variants of SARS-CoV-2 and Novel Therapeutics against Coronavirus (COVID-19). StatPearls. StatPearls Publishing Copyright © 2021, FL: StatPearls Publishing LLC.; 2021
• 3 Acosta R, Smit JM, Audolfsson T. et al. A clinical review of 9 years of free perforator flap breast reconstructions: an analysis of 675 flaps and the influence of new techniques on clinical practice. J Reconstr Microsurg 2011; 27 (02) 91-98
• 4 Fadavi D, Haley A, Khavanin N. et al. Postoperative free flap breast protocol optimizing resources and patient safety. J Reconstr Microsurg 2020; 36 (05) 379-385
• 5 American College of Surgeons. COVID-19 Recommendations for Management of Elective Surgical Procedures. Accessed May 1, 2022 at: https://www.facs.org/covid-19/clinical-guidance/elective-surgery
• 6 Khalafallah AM, Jimenez AE, Lee RP. et al. Impact of COVID-19 on an academic neurosurgery department: the Johns Hopkins experience. World Neurosurg 2020; 139: e877-e884
• 7 Rashid HU, Rashid M, Khan N, Ansari SS, Bibi N. Taking a step down on the reconstruction ladder for head and neck reconstruction during the COVID-19 pandemic. BMC Surg 2021; 21 (01) 120
• 8 Monthly TA. The COVID Tracking Project. Accessed March 20, 2021 at: https://covidtracking.com/
• 9 Nitkin K. Milestones in a Year of COVID-19 at Johns Hopkins Medicine; 2021. Accessed May 7, 2021 at: https://www.hopkinsmedicine.org/news/articles/covid-19-timeline-for-johns-hopkins-medicine
• 10 Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009; 41 (04) 1149-1160
• 11 Berman ZP, Diep GK, Alfonso AR. et al. Plastic surgery amidst the pandemic: the New York University experience at the epicenter of the COVID-19 crisis. Plast Reconstr Surg 2021; 148 (01) 133e-139e
• 12 Chi D, Chen AD, Dorante MI, Lee BT, Sacks JM. Plastic surgery in the time of COVID-19. J Reconstr Microsurg 2021; 37 (02) 124-131
• 13 Ho MK, Chau CYC. Plastic and reconstructive surgery during the COVID-19 pandemic: impacts on healthcare workers, financing, and governance. Arch Plast Surg 2022; 49 (01) 127-129
• 14 Jalisi S, Chen AD, Gomez E. et al. A multidisciplinary approach and review of safety recommendations for plastic surgeons during the COVID-19 pandemic: are N95 masks enough?. Plast Reconstr Surg 2021; 148 (02) 467-474
• 15 Mehrabian D, Liu IZ, Pakhchanian HH, Tarawneh OH, Raiker R, Boyd CJ. Nationwide analysis of plastic and reconstructive procedural volume in the United States during the COVID-19 pandemic. J Plast Reconstr Aesthet Surg 2021:S1748-6815(21)00645-8
• 16 Shibata D, Kawate T, Komiya T, Nakamura I, Ishikawa T, Matsumura H. Impact of the COVID-19 pandemic on breast surgery and breast reconstruction in a Japanese university hospital setting. Arch Plast Surg 2022; 49 (01) 132-136
• 17 COVIDSurg Collaborative. Head and neck cancer surgery during the COVID-19 pandemic: an international, multicenter, observational cohort study. Cancer 2020; 127 (14) 2476-2488
• 18 Chong S, Hung R, Gwozdz A. et al. 30-Day postoperative COVID-19 outcomes in 398 patients from regional hospitals utilising a designated COVID-19 minimal surgical site pathway. Ann R Coll Surg Engl 2021; 103 (06) 395-403
• 19 Clement ND, Hall AJ, Makaram NS. et al. IMPACT-Restart: the influence of COVID-19 on postoperative mortality and risk factors associated with SARS-CoV-2 infection after orthopaedic and trauma surgery. Bone Joint J 2020; 102-B (12) 1774-1781
• 20 Luo W, Limb R, Aslam A. et al. COVID-19 pandemic did not affect emergency theatre patient demographic and length of stay in the first phase of UK countrywide lockdown in a district general hospital. Ann R Coll Surg Engl 2021; 103 (06) 404-411
• 21 Patel NG, Reissis D, Mair M. et al; ReconSurg Collaborative. Safety of major reconstructive surgery during the peak of the COVID-19 pandemic in the United Kingdom and Ireland - multicentre national cohort study. J Plast Reconstr Aesthet Surg 2021; 74 (06) 1161-1172
• 22 Kain JJ, Johns JD, Alexander D, Carroll WR, Grayson JW, Buczek EJ. Improving head and neck microvascular reconstructive care with a novel perioperative checklist. Laryngoscope 2021; 131 (07) E2251-E2256
• 23 Cárdenas-Camarena L, Bayter-Marin JE, Durán H. et al. Elective surgery during SARS-Cov-2/COVID-19 pandemic: safety protocols with literature review. Plast Reconstr Surg Glob Open 2020; 8 (06) e2973
• 24 Payton JI, Wong S, Lombana NF, Saint-Cyr MS, Altman AM, Brooke SM. Microsurgery in the era of COVID-19. Proc Bayl Univ Med Cent 2021; 34 (02) 269-273